bayer ag-reg (BAYN:Xetra)
bayer ag-reg (BAYN) Snapshot
|
Open
€83.43
|
Previous Close
€83.40
|
|
|
Day High
€84.13
|
Day Low
€82.65
|
|
|
52 Week High
05/28/13 - €87.21
|
52 Week Low
06/25/12 - €51.81
|
|
|
Market Cap
69.4B
|
Average Volume 10 Days
2.0M
|
|
|
EPS TTM
€3.09
|
Shares Outstanding
826.9M
|
|
|
EX-Date
04/29/13
|
P/E TM
27.1x
|
|
|
Dividend
€1.90
|
Dividend Yield
2.26%
|
bayer ag-reg (BAYN) Related Businessweek News
bayer ag-reg (BAYN) Details
Bayer Aktiengesellschaft develops, produces, and markets health care and agriculture products, and high-tech materials worldwide. The company’s HealthCare segment provides pharmaceuticals, such as prescription pharmaceuticals for the treatment of hypertension, cardiovascular and infectious diseases, cancer, multiple sclerosis, and contraception. This segment also offers consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements for humans and animals, and veterinary pharmaceuticals and grooming products for livestock and companion animals. In addition, it manufactures medical care products, including blood glucose monitoring devices, such as single-strip systems and multi-strip systems; USB meters comprising integrated diabetes management software and direct plug-in to computers; systems for determining long-term blood glucose control; contrast agent injection systems for diagnostic and therapeutic medical procedures in X-ray, computed tomography, and magnetic resonance imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. Bayer Aktiengesellschaft’s CropScience segment provides insecticides, fungicides, herbicides, and seed treatment products; products in the areas of seeds and plant traits, for gardens, and the green industry; and non-agricultural pest and weed control products. The company’s MaterialScience segment offers materials in the field of polyurethanes and polycarbonates; coating and adhesive raw materials; plastics sheets and functional films; and inorganic basic chemicals, such as chlorine, sodium hydroxide solution, hydrogen, hydrochloric acid, and nitric acid. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cells. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
bayer ag-reg (BAYN) Top Compensated Officers
bayer ag-reg (BAYN) Key Developments
Bayer AG Presents at Citi European Healthcare One-on-One Conference, Jun-18-2013 . Venue: Stirling Square, 5-7 Carlton Gardens, London SW1Y 5AD, United Kingdom. Speakers: Alexander Rosar, Head of Investor Relations, Olaf Weber, IR Manager.
Bayer AG reported group earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported sales of €10,266 million compared to €10,054 million for the same period in the last year. EBIT was €1,771 million compared to €1,631 million for the same period in the last year. EBITDA was €2,416 million compared to €2,378 million for the same period in the last year. Net income was €1,160 million or €1.40 per share compared to €1,040 million or €1.26 per share for the same period in the last year. Net cash flow advanced by 38.0% to €327 million compared to €237 million in 2012. The company provided earnings guidance for the year 2013. Group sales of approximately €41 billion targeted for 2013. The company plans to increase EBITDA before special items by a mid-single-digit percentage and core earnings per share by a high-single-digit percentage.
Bayer AG Presents at 2013 BIO International Convention, Apr-23-2013 03:45 PM. Venue: McCormick Place - Chicago Bulls Room, 2301 S. Lake Shore Drive, Chicago, IL 60616, United States. Speakers: Chris Seaton.

| Recently Viewed | |||
| BAYN:GR | €83.89 EUR | +0.487 | |
| Company | Last | Change |
| 3M Co | $112.97 USD | +1.06 |
| Abbott Laboratories | $37.51 USD | +0.62 |
| Saudi Basic Industries Corp | SR93.25 SAR | +1.00 |
| Dow Chemical Co/The | $34.62 USD | +0.48 |
| Unilever NV | €30.39 EUR | -0.21 |
| View Industry Companies | ||
Industry Analysis
BAYN
Industry Average
| Valuation | BAYN | Industry Range |
| Price/Earnings | 28.1x |
|
| Price/Sales | 1.8x |
|
| Price/Book | 3.7x |
|
| Price/Cash Flow | 28.1x |
|
| TEV/Sales | 1.5x |
|
Post a JobJobs
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
- Orlando, FL | Consult SoftPosted: May 22
Sponsored Financial Commentaries
Sponsored Links
To contact BAYER AG-REG, please visit www.bayer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








